Medications for Rapid Sequence Induction

Learning Objectives
Recall indications and contraindications for rapid sequence induction (RSI) in pediatric ICU patients
Explain the physiologic rationale for pre‑oxygenation and apnea tolerance during RSI
Apply a safe, stepwise approach to medication selection and sequencing for RSI
Analyze airway anatomy and aspiration risk to determine when RSI should not be used
Evaluate risks associated with paralysis, cricoid pressure, and apnea during RSI and implement strategies to mitigate harm
Author(s)
Robert Pascucci, MD
Anesthesiology | Boston Children's Hospital
Traci Wolbrink, MD, MPH
Co-Director, OPENPediatrics; Co-Director, Center for Educational Excellence and Innovation; Program Director, Pediatric Critical Care Medicine Fellowship; Senior Associate in Critical Care Medicine | Boston Children’s Hospital
Associate Professor of Anaesthesia | Harvard Medical School
Citation
Pascucci R, Wolbrink TA. Medications for Rapid Sequence Induction. 9/2012. Online Video. OPENPediatrics. https://learn.openpediatrics.org/learn/course/internal/view/elearning/3048/medications-for-rapid-sequence-induction.
